Back to Journals » Biologics: Targets and Therapy » Volume 9 » default

Biologics: Targets and Therapy


Archived Journals

Archive: Volume 9, 2015

Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis

Sangiorgi D, Benucci M, Nappi C, Perrone V, Buda S, Degli Esposti L

Biologics: Targets and Therapy 2015, 9:119-127

Published Date: 6 November 2015

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al

Thomsen SF, Sand FL

Biologics: Targets and Therapy 2015, 9:117-118

Published Date: 6 November 2015

Role of collagenase clostridium histolyticum in Peyronie's disease

Peak TC, Mitchell GC, Yafi FA, Hellstrom WJ

Biologics: Targets and Therapy 2015, 9:107-116

Published Date: 29 September 2015

Clinical utility of ramucirumab in advanced gastric cancer

Chan MMK, Sjoquist KM, Zalcberg JR

Biologics: Targets and Therapy 2015, 9:93-105

Published Date: 22 September 2015

Effect of mild aerobic training on the myocardium of mice with chronic Chagas disease

Preto E, Lima NEA, Simardi L, Fonseca FLA, Fragata Filho AA, Maifrino LBM

Biologics: Targets and Therapy 2015, 9:87-92

Published Date: 23 September 2015

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia

Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M

Biologics: Targets and Therapy 2015, 9:75-86

Published Date: 18 September 2015

Giant-cell tumor of bone: treatment options and role of denosumab

Singh AS, Chawla NS, Chawla SP

Biologics: Targets and Therapy 2015, 9:69-74

Published Date: 14 July 2015

Localization and upregulation of survivin in cancer health disparities: a clinical perspective

Khan S, Ferguson Bennit H, Asuncion Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE, Ashok A, Wall NR

Biologics: Targets and Therapy 2015, 9:57-67

Published Date: 9 July 2015

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]

Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno GB, Incorvaia C

Biologics: Targets and Therapy 2015, 9:45-46

Published Date: 29 June 2015

Biologic monotherapy in the treatment of rheumatoid arthritis

Detert J, Klaus P

Biologics: Targets and Therapy 2015, 9:35-43

Published Date: 14 May 2015

Role of biologics in intractable urticaria

Cooke A, Bulkhi A, Casale TB

Biologics: Targets and Therapy 2015, 9:25-33

Published Date: 13 April 2015

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Bardy-Bouxin N, Matczak E, Devgan G, Woloj M, Shapiro M

Biologics: Targets and Therapy 2015, 9:23-24

Published Date: 19 February 2015

Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins

Benucci M, Li Gobbi F , Meacci F, Manfredi M, Infantino M, Severino M, Testi S, Sarzi-Puttini P, Ricci C, Atzeni F

Biologics: Targets and Therapy 2015, 9:7-12

Published Date: 17 February 2015